Overview
- 4 public-safe observations are available for this inspection.
- 3 structured CFR citations are represented.
- 2 investigators are tied to this Form 483.
Inspectional observations
Each observation cites the regulation FDA found the firm out of compliance with.
16 Dec 2019
21 CFR 610.40(c)(2)
Device component - labeling
Cited by Brentley S Collins, Doretha M Tonkins
16 Dec 2019
21 CFR 630.15(b)(1)
Medical history and physical exam
Cited by Brentley S Collins, Doretha M Tonkins
Inspected site
SBSpecialty Blood CenterCharleston, United States
Inspection team
Cited regulations
CFR citations associated with this Form 483.
| Citation | What it covers | Cited |
|---|---|---|
| 21 CFR 630.40(c) | Cited across public-safe Form 483 observations | 2x |
| 21 CFR 610.40(c)(2) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 630.15(b)(1) | Cited across public-safe Form 483 observations | 1x |
Source document
PDF
PDF available
Form 483 source document
The source document is available to authorized Atlas users.
Full 483 report
Get the verbatim text of all 4 observations
The source PDF, so your team sees exactly what was cited and how it was answered.
- The site's full inspection history around this Form 483
- Whether these citations escalated to a warning letter
- The investigators involved and the citations they repeat elsewhere